Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-09-18
1995-08-15
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514908, 536103, A61K 3170, C08B 3702, C08B 3716
Patent
active
054419441
ABSTRACT:
The invention relates to highly water soluble substituted .alpha.-, .beta.- or .gamma.-cyclodextrin sulfates associated with a physiologically acceptable cation. Pathological or otherwise undesirable cell or tissue growth in mammals, including humans, is inhibited by administering thereto (1) a water-soluble substituted cyclodextrin sulfate salt, together with (2) a growth-inhibiting organic compound. The growth-inhibiting compound (2) may be asteroid having no inhibiting effect in the absence of (1), or an organic compound which may be an active growth inhibitor, the action of which is potentiated by (1). The invention provides a method for inhibiting angiogenesis and controlling the growth of tumors as well as treating other diseases and pathological conditions associated with undesired cell or tissue growth, including angiogenesis.
REFERENCES:
patent: 2923704 (1960-02-01), Berger et al.
patent: 3420788 (1969-01-01), Solms
patent: 4020160 (1977-04-01), Bernstein et al.
patent: 4066829 (1978-01-01), Nair et al.
patent: 4247535 (1981-01-01), Lewis et al.
patent: 4258180 (1981-03-01), Lewis et al.
patent: 4383992 (1983-05-01), Lipari
patent: 4582900 (1986-04-01), Brandt et al.
patent: 4596795 (1986-06-01), Pitha
patent: 4727064 (1988-02-01), Pitha
patent: 4764604 (1988-08-01), Muller
patent: 4834985 (1989-05-01), Elger et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4877774 (1989-10-01), Pitha et al.
patent: 4877778 (1989-10-01), Carpenter et al.
patent: 4902788 (1990-02-01), Zemel et al.
patent: 5019562 (1991-05-01), Folkman et al.
Croft et al., Tetrahedron, vol. 39, pp. 1417-1474 (1983).
Nakashima et al., Antimicrobial Agents and Chemotherapy, pp. 1524-1528 (1987).
Uekama et al., International Journal of Pharmaceutics, vol. 10, pp. 1-15 (1982).
J. Pitha et al., Journal of Pharmaceutical Sciences, vol. 75(2), pp. 165-167 (1986).
Chemical Abstracts 83:79544a (1975).
Fenyvesi et al., Chem. Pharm. Bull., vol. 32(2), pp. 665-669 (1984).
Fenyvesi et al., Chem. Pharm. Bull., vol. 32(2), pp. 670-677 (1984).
Komiyama et al., Polymer Journal, vol. 18(4), pp. 375-377 (1986).
Chemical Abstracts, 96:218351U (1982).
Herrmann, H. C., Abstracts of Papers, National Meeting of the American Heart Association, Ahaheim, Calif.; Nov. 11-14, 1991.
Yamamoto et al., International Journal of Pharmaceutics, vol. 49, pp. 163-171 (1989).
J. Folkman et al., Science, vol. 235, pp. 442-447 (1987).
J. Folkman et al., Cancer Research, vol. 46, pp. 467-473 (1986).
Shubik et al., J. Nat'l. Cancer Inst., vol. 57, pp. 769-774 (1976).
Gross et al., Proc. Nat'l. Acad. Sci. USA, vol. 78, pp. 1176-1180 (1981).
R. Crum et al., Science, vol. 230, pp. 1375-1378 (1985).
J. Folkman et al., Annals of Surgery, vol. 206, pp. 374-383 (1987).
Gimbrone et al., J. Nat'l. Cancer Inst., vol. 52, pp. 413-426 (1973).
J. Folkman et al., Science, vol. 221, pp. 719-725 (1983).
Snow et al., Human Pathology, vol. 18, pp. 506-510 (1987).
Ewing William R.
Joullie Madeleine M.
Weisz Paul B.
Griffin Ronald W.
The Trustees of the University of Pennsylvania
LandOfFree
Substituted cyclodextrin sulfates and their uses as growth modul does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclodextrin sulfates and their uses as growth modul, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclodextrin sulfates and their uses as growth modul will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2181884